NovAccess Global Announces New License to Advance its Immunotherapy Platform [Yahoo! Finance]
NOVACCESS GLOBAL INC (XSNX)
NASDAQ:AMEX Investor Relations:
xsunx.com/investors/investor-faqs
Company Research
Source: Yahoo! Finance
suffering from cancers of the central nervous system, today announced the procurement of a new intellectual property license from Cedars-Sinai Medical Center to further advance the Company's immunotherapy platform. The license pertains to the use of Isocitrate Dehydrogenase-1 (IDH1), a protein previously known to impact cell metabolism. The Company intends to leverage this license to predict a patient's likely response to vaccine immunotherapy during treatment for highly malignant brain tumors, such as glioblastoma. IDH1 is commonly mutated in brain and other tumors. Groundbreaking research published by Dr. Chris Wheeler, President and lead scientist of NovAccess Global's subsidiary StemVax, LLC, has shown that IDH1 predicts antitumor responses after vaccine therapy through a novel molecular mechanism. The Company assesses that IDH1 expression is likely to discern long-duration from short-duration survivors after vaccine therapy in patients with brain tumors such as glioblastoma. In
Show less
Read more
Impact Snapshot
Event Time:
XSNX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
XSNX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
XSNX alerts
High impacting NOVACCESS GLOBAL INC news events
Weekly update
A roundup of the hottest topics
XSNX
News
- NovAccess Global Advisory on Annual Meeting of ShareholdersAccesswire
- NovAccess Global Announces New License to Advance its Immunotherapy PlatformAccesswire
- NovAccess Global Provides Business Updates and Announces Scheduling of Annual Meeting of Shareholders [Yahoo! Finance]Yahoo! Finance
- NovAccess Global Provides Business Updates and Announces Scheduling of Annual Meeting of ShareholdersAccesswire
XSNX
Sec Filings
- 5/15/24 - Form 10-Q
- 5/3/24 - Form 8-K
- 4/24/24 - Form 10-K/A
- XSNX's page on the SEC website